Max, a basic ± helix ± loop ± helix ± leucine zipper (bHLH-ZIP) protein, plays a central role in the transcriptional regulation of myc oncoprotein-responsive genes. Myc-max heterodimers bind to consensus E-box motifs near or within the promoters of these genes and activate gene expression, whereas heterodimers between max and members of the mad family of bHLH-ZIP proteins promote transcriptional repression. In contrast to all other members of the myc network, max readily homodimerizes and binds to identical E-box sites in vitro. However, the role for max homodimers in transcriptional repression in vivo is unclear. Upstream stimulatory factor (USF) is a bHLH-ZIP protein which does not interact with members of the myc-max-mad family. By replacing the HLH-ZIP domain of max with that from USF, we created a chimeric protein, max(USF), which was indistinguishable from max with respect to its ability to homodimerize and bind DNA. As expected, however, max(USF) was unable to heterodimerize with any of the tested max partner proteins and was incapable of suppressing c-myc target genes. Thus, transcriptional repression is an exclusive property of max-mad heterodimers and cannot be achieved by max homodimers alone.
Introduction
Considerable evidence indicates that the basic ± helix ± loop ± helix ± leucine zipper (bHLH-ZIP) protein max plays a central role in transcriptional regulation by myc oncoproteins. Max readily dimerizes with the three major myc proteins (c-myc, N-myc, and L-myc) both in vitro and in vivo, and greatly augments their binding to consensus DNA sites termed E-boxes (Blackwood and Eisenman, 1991; Prendergast et al., 1991; Mukherjee et al., 1992; Blackwood et al., 1992) . This leads to the transcription of E-box-containing genes (Kretzner et al., 1992b; Amin et al., 1993; Gu et al., 1993) , an activity mediated by transactivation domains (TADs) in the amino termini of the myc proteins (Kato et al., 1990) . Because myc homodimerization does not occur under physiologic conditions, it is generally accepted that the biological activities of myc proteins, including those pertaining to proliferation, transformation, and apoptosis, require an association with max , 1993a ,b, Billaud et al., 1993 .
In addition to its ability to heterodimerize with myc proteins, max also homodimerizes and, at least in vitro binds to the same E-boxes as myc-max heterodimers (Blackwood and Eisenman, 1991; Prendergast et al., 1991; Berberich and Cole, 1992; Prochownik and Van Antwerp, 1993) . Although the co-expression of c-myc and max in vivo stimulates transcription at low max : myc ratios, transcriptional repression is seen at higher ratios or in the absence of exogenous c-myc (Prendergast et al., 1991; Kretzner et al., 1992a; Amin et al., 1993; Gu et al., 1993; Lee et al., 1995; Zhang et al., 1997) . This observation led to a simple model of gene regulation by myc and max proteins (Amati et al., 1993a,b; Kretzner et al., 1993b) . Under conditions of relative myc excess, this model predicted that myc-max heterodimers are energetically favored and thus are the predominant E-box binding species. Excess max, or reduced myc, leads to the formation of max homodimers which compete successfully with mycmax heterodimers for E-box occupancy, and repress transcription of myc target genes. The degree to which max-mediated repression could occur in vivo, however, was unclear due to the additional observation that phosphorylation of the protein by casein kinase II (CKII) could prevent DNA binding by max homodimers but not by myc-max heterodimers (Berberich and Cole, 1992; Prochownik and VanAntwerp, 1993; Koskinen et al., 1994) .
The above model has been substantially modi®ed following the identi®cation of the Mad family of bHLH-ZIP proteins. This group consist of at least four related members, Mad1, Mxi1, Mad3, and Mad4 which, like myc, also homodimerize poorly but which heterodimerize with max and bind to E-boxes Zervos et al., 1993; Hurlin et al., 1995b) . The ensuing transcriptional repression occurs through an active process involving the binding of one of more additional proteins related to the yeast transcriptional repressor SIN3 (Ayer et al., 1995; Schreiber-Agus et al., 1995 Kastan et al., 1996 . In turn, mSin3 (the mammalian homolog of SIN3) binds at least two proteins, a transcriptional co-repressor termed N-CoR/ SMRT and two histone deacetylases, HDAC1 and HDAC2, the mammalian homologs of the yeast protein Rpd3 (Hassig et al., 1997; Laherty et al., 1997; Heinzel et al., 1997; Alland et al., 1997) . A highly conserved 30 amino acid segment at the extreme amino terminus of each Mad protein, termed the SID domain, is required for mSin3 binding (Ayer et al., 1995; Schreiber-Agus et al., 1995) . Mnt, a more recently described bHLH-ZIP protein that heterodimerizes with max, is not considered to be a member of the Mad family, although it contains a SID-like domain that is required for transcriptional repression of myc-mediated transcription (Hurlin et al., 1997) .
Whereas the expression of Mnt is fairly widespread (Hurlin et al., 1997) , the expression of the Mad proteins is more restricted and complex. Some, such as Mad1 and Mad4, are expressed primarily in postmitotic, dierentiated cells in a pattern that correlates inversely with the presence of c-myc Larsson et al., 1994; Hurlin et al., 1995a; Vastrik et al., 1995) . In contrast, other members, particularly Mxi1, are expressed by proliferating cells at quite high levels which change little during dierentiation (Zervos et al., 1993; Hurlin et al., 1995a; Larsson et al., 1994) .
The above observations suggest that most, if not all, of the transcriptional repression of myc-responsive genes is achieved through an active process involving mad-max or mnt-max heterodimers. Any max that did homodimerize would be prevented from binding DNA by CKII-mediated phosphorylation. Since max does not possess a SID domain, any unphosphorylated max homodimers would probably produce transcriptional repression by passive mechanisms involving simple competition with myc-max heterodimers.
The complex and variable expression patterns of mad proteins, together with other factors that may aect their interactions with max, make it dicult to provide an accurate assessment of the relative contribution, if any, of max homodimers to transcriptional repression. To address this problem in a meaningful and generalizable way, we elected to study the properties of an engineered max protein that dimerizes and binds c-myc E-boxes normally but is unable to interact with any other member of the myc network. This protein, which we term max(USF), consists of a full-length max protein in which the HLH-ZIP domain has been precisely replaced by the corresponding region from upstream stimulatory factor (USF) (Gregor et al., 1990) . All other features of max, including the DNA binding basic domain, were retained. Our ®nding that max(USF) is unable to mediate repression of c-myc responsive genes suggests that, to whatever degree max homodimerization does occur in vivo, it exerts no eect on transcriptional repression.
Results

Construction of Max(USF)
In order to determine whether max homodimers were active in transcriptional repression, we sought to create a max molecule capable of homodimerizing and binding DNA but incapable of interacting with other members of the myc network. This was accomplished by replacing the HLH-ZIP domain of Max with that from USF. USF was chosen for this purpose as its previously determined crystal structure indicated a high degree of similarity between its HLH-ZIP domain and that of max (Ferre-D'Amare et al., 1993; , because USF, like max, readily homodimerizes (Gregor et al., 1990) , and because the USF HLH-ZIP domain has not been previously reported to interact with any known members of the myc network. The hybrid molecule, termed max(USF), retained all other structural features of max, including its DNA binding basic domain.
Characterization of max(USF)
A yeast two-hybrid assay was initially used to determine whether max(USF) could interact with various members of the myc network. In this assay, full-length max and max(USF) were expressed as fusion proteins with the DNA binding domain of the yeast Gal4 protein in the low copy plasmid pGBT9 (the`bait' plasmid) (Bartel et al., 1993; Anand et al., 1997; . Myc network proteins, including max and max(USF), were expressed as a fusion with the Gal4 transactivation domain in the pGAD424 vector (the`prey' plasmid). Interactions between bait and prey-encoded proteins conveyed histidine prototrophy to the yeast strain and the ability to produce b-galactosidase as previously described . As shown in Table 1 , max interacted strongly and speci®cally with c-myc and with all four members of the Mad family (lines 9 ± 13). In contrast, max(USF) failed to interact with any of the above preys (lines 17 ± 21). In keeping with previously reported observations using low copy number vectors Fisher et al., 1993) , neither max nor max(USF) interacted with themselves (lines 3 and 16). These observations are consistent with the notion that mycmax and Mad-max heterodimerization is favored over max homodimerization.
The ®nding that max(USF) did not interact with any of the tested myc network proteins suggested that, as predicted, their HLH-ZIP domains were incompatible. However, it was also possible that max(USF) was either not expressed or was improperly folded. To examine this more thoroughly, Western blots of total yeast lysates were probed with anti-Gal4 antibodies. Both max-and max(USF)-Gal4 fusion proteins were The indicated pGBT9-and pGAD424-encoded proteins were coexpressed in yeast and then tested for histidine prototrophy and the expression of b-galactosidase using an in situ ®lter assay. (+): strong blue colour detectable within 1 h; (7) no detectable colour with an overnight incubation. Similar results were obtained with the`bait' and`prey' cDNAs in the opposite vectors (not shown) P-labeled EO(GAC) c-myc binding site oligonucleotide in a total volume of 20 ml for 20 min at room temperature. In lanes 1 ± 7 incubations were performed in the presence of 1 mg of pre-immune IgG whereas in lanes 8 ± 14, the incubation were performed in the presence of 1 mg of anti-max IgG (Zhang et al., 1997) . Complexes were resolved by non-denaturing gel electrophoresis followed by autoradiography readily detected when expressed in either the pGBT9 or pGAD424 vector (Figure 1a, b) . In order to determine whether these proteins were functional, we prepared total yeast cell extracts and performed an electrophoretic mobility shift assay (EMSA) using a 32 Plabeled oligonucleotide containing a consensus c-myc binding site. Extracts from yeast expressing either max or max(USF) in either the pGBT9 or pGAD424 vector produced a shifted complex whereas extracts from yeast transfected with the parental vectors alone contained virtually no binding activity (Figure 1c) . In addition, all four max and max(USF) complexes could be`supershifted' by the addition of anti-Max antibody ( Figure 1c, lanes 8 ± 12) . Taken together, the results of Table 1 and Figure 1 indicated that max and max(USF), were expressed at equivalent levels, homodimerized, and bound equivalently to a c-myc target site. However, whereas max was capable of forming heterodimers with its appropriate partners, max(USF) was not. Although both max and max(USF) homodimerized in yeast, the detection of these complexes required a more sensitive electrophoretic mobility shift assay.
To con®rm and extend the above results, full-length max and max(USF) cDNAs were expressed as hexahistidine tagged fusion proteins in E. coli and then tested for their DNA binding ability, either alone, or together with an equimolar amount of c-myc, Mad1, Mxi, Mad3 or Mad4. Using standard EMSA conditions (Prochownik and VanAntwerp, 1993) , none of the individual proteins except max and max(USF) was able by itself to produce a detectable shift of the labeled oligonucleotide (Figure 2 lanes 2 ± 8) . This is compatible with what many other groups have found for the myc network proteins Zervos et al., 1993; Hurlin et al., 1995b) . However, when c-myc or any of the Mad proteins was mixed with max, new DNA binding complexes were observed indicating the formation of myc-max or Mad-max heterodimers (lanes 10 ± 15). In contrast, none of these proteins produced a shifted complex when mixed with max(USF) (lanes 17 ± 22). These results were consistent with our observations in yeast and provided independent con®rmation that max(USF) was unable to interact with any of the myc family member proteins.
CKII-mediated phosphorylation of serine residues at positions 2 and 11 in max has been previously shown to exert a negative eect on DNA binding (Berberich and Cole, 1992; Bousset et al., 1993; Prochownik and VanAntwerp, 1993; Koskinen et al., 1994) . Since the entire amino-terminus of max(USF), up to and including the basic domain, is intact, we predicted that CKII-mediated down-regulation of DNA binding would occur in a manner that was indistinguishable from that of max. That this was true is shown in Figure 3a . As we and others have shown previously (Berberich and Cole, 1992; Prochownik and Van Antwerp, 1993) , the incubation of both max and max(USF) with a CKII-rich rabbit reticulocyte lysate resulted in the complete loss of DNA binding. This correlated well with the in vitro phosphorylation of the proteins that was seen following the inclusion of [ 32 P-g]-ATP in the reticulocyte lysate and resolving the products by SDS ± PAGE (Figure 3b) . From these and the other in vitro experiments described above, we conclude that max(USF) exhibits behavior very similar to that of max except for its ability to form heterodimers with known max partner proteins.
Max(USF) fails to repress transcription in vivo of c-myc-responsive genes
Many groups have demonstrated the ability of transiently transfected max to suppress the transcription of c-myc-responsive promoters, particularly when max is present in excess (Kretzner et al., 1992a; Amin et al., 1993; Gu et al., 1993; Zhang et al., 1997) . To determine whether transcriptional repression could also be achieved with max(USF), we tested it in a transient transfection assay with two c-myc-responsive promoters. In the ®rst case, a synthetic promoter was derived by positioning three tandemly repeated consensus cmyc binding sites immediately upstream of an adenovirus E1b minimal promoter element driving the expression of a luciferase reporter (Gupta et al., 1993) . In the second case, the c-myc responsive ODC promoter was used to drive the expression of a CAT reporter (Bello-Fernandez et al., 1993) . Each of these constructs was transiently expressed in NIH3T3 cells to determine whether its c-myc-inducible expression could Electrophoretic mobility shift assays were performed as described in the legends to Figure 1 and 2 using 20 ng of puri®ed, hexahistidine-tagged, bacterially-expressed max or max(USF) (lanes 2 and 3, respectively). In lanes 4 and 5, the proteins were pre-incubated with 5 ml of a CKII-rich rabbit reticulocyte prior to the addition of the labeled EO(GAC) oligonucleotide. (b) An aliquot of each protein in panel A was incubated for 30 min at 378C with reticulocyte lysate in the presence of 10 mCi of [ 32 P-g]ATP as previously described (Prochownik and VanAntwerp, 1993) . The reaction was then resolved by SDS ± PAGE, dried, and subjected to autoradiography. Lane 1 contained reticulocyte lysate only with no added recombinant max or max(USF) proteins. Lanes 2 and 3 show that max and max(USF) were equally well phosphorylated Lack of transcriptional repression by max X Yin et al be extinguished by co-expressed max(USF). As a positive control, a max expression vector (Zhang et al., 1997) was tested in parallel transfection experiments. As shown in Figure 4 , max eciently suppressed the expression of both reporter constructs in a dose-dependent manner. In marked contrast, max(USF) demonstrated no suppression of either reporter, even at the highest concentrations tested. Similar results were obtained in the absence of cotransfected c-myc (Figure 4c and d) .
In order to con®rm the dierences between max and max(USF), as well as to show that they were not due to a failure of the latter protein to be expressed, we stably expressed each protein in the interleukin-3-dependent 32D murine myeloid cell line (Valtieri et al., 1987; Zhang et al., 1997) . The resultant pooled, G-418-resistant clones were designated 32D-max or 32D-max(USF) to denote the identity of the expressed protein. A control group of pooled clones, designated 32D-neo, were derived following transfection with the (Gupta, et al., 1993) , together with the indicated amounts of c-myc, max or max(USF) expression plasmids (Zhang et al., 1997) . All plates also received 3 mg of pCMV-b-gal (Clontech) as a control for transfection eciency. Two days later, plates were harvested and assayed for b-galactosidase and luciferase activities. The results shown represent the average + one standard error for three sets of experiments, each performed in duplicate. (b) Experiments were performed as described in (a) except that the ODC-CAT reporter plasmid (Bello-Fernandez et al., 1993) was used. (c, d) Experiments were performed as described in a and b, respectively, except tht no c-myc expression plasmid was co-transfected empty parental vector. Each cell line was then metabolically labeled and max proteins were immunoprecipitated. As seen in Figure 5a , both max and max(USF) were expressed at equivalent levels, thus indicating that both plasmids were functional and that the substitution of the HLH-ZIP domain in max with that from USF did not destabilize the chimeric protein.
We have previously shown that stable expression of the 160 amino acid isoform of max results in a signi®cant reduction in the level of endogenous ODC (Zhang et al., 1997) . Therefore, we compared the levels of this enzyme in the three cell lines described above. As shown in Figure 5b , the level of ODC in 32D-max cells was reduced approximately ®vefold in comparison to that of 32D-neo cells. In contrast, ODC levels in 32D-max(USF) cells were identical to those in the control cell line. From these experiments, we conclude that whereas either the transient or stable expression of max is able to suppress the transcription of c-mycresponsive promoters, max(USF) completely lacks this capability.
Discussion
Max is a bHLH-ZIP protein that plays a central role in both the positive and negative transcriptional regulation of myc oncoproteins (Blackwood and Eisenman, 1991; Prendergast et al., 1991; Mukherjee et al., 1992; Kretzner et al., 1992a,b; Amin et al., 1993; Gu et al., 1993) . In the ®rst case, positive regulation is achieved by binding of the myc-max heterodimer to a consensus E-box sequence (Blackwood and Eisenman, 1991; Prendergast et al., 1991) . Transcriptional activation is then mediated by a TAD encoded by the amino terminus of myc (Kato et al., 1990) . Negative regulation was initially postulated to occur through the formation of max homodimers, which, lacking TADs (Min and Taparowsky, 1992; Kato et al., 1992) , would compete with myc-max heterodimers for the same E-box sequences (Kretzner et al., 1992a, b) . More recently, negative regulation has been shown to result from the association between max and one of at least ®ve bHLH-ZIP proteins, Mad1 ± 4 and Mnt Zervos et al., 1993; Hurlin et al., 1995b; Hurlin et al., 1997) . The role for max homodimers in mediating transcriptional repression has been further questioned by the ®nding that DNA binding by max homodimers is inhibited by CKII-mediated phosphorylation (Berberich and Cole, 1992; Prochownik and VanAntwerp, 1993; Koskinen et al., 1994) . Together, these observations suggest that much, if not all, of max is unable to bind DNA as a homodimer due to its various heterodimeric associations and/or its posttranslational modi®cation. The contribution made by each of these factors is likely to be highly variable due to the dierential expression of Mad members among various cell types and to the presumed dynamic equilibrium that exists among the heterodimeric pairs. Such complexity makes it dicult both to assess the importance of any particular dimer in mediating transcriptional repression and to generalize this contribution to other cell types.
In order to circumvent the above diculties, we elected to take a genetic approach to determining what role, if any, max homodimers play in the transcriptional repression of myc-regulated genes. By replacing the HLH-ZIP domain of max with that from USF, which possesses a similar structure (Ferre-D'Amare et al., 1993; , we have shown that the resulting chimeric protein, max(USF), is indistinguishable from wild-type max in regard to its DNA binding, its regulation by CKII-mediated phosphorylation, and its in vivo expression and stability. Despite these similarities, max(USF) was unable to interact with any of the tested members of the myc family. This property had been predicted based on the inability of USF to interact with any known myc family member (Table 1) . Max(USF) was also unable to mediate repression of either transiently expressed or endogenous c-myc-responsive genes. Our observations thus strongly suggest that, despite the ease with which max homodimerization and DNA binding normally occur in vitro (Blackwood and Eisenman, 1991; Prendergast et al., 1991; Berberich and Cole, 1992; Prochownik and VanAntwerp, 1993) , these attributes are not sucient to allow transcriptional repression in vivo. Rather, this activity seems to be mediated solely by the various heterodimeric associations described above.
Although homodimerization and DNA binding can be observed for a number of bHLH-ZIP and bHLH proteins such as myc and MyoD, these properties are generally seen only at excessively high protein concentrations that are not thought to be achievable in vivo (Blackwell et al., 1990; Dang et al., 1989; Smith et al., 1990) . On the other hand, max readily homodimerizes at low concentrations. In the absence of any contribution to transcriptional repression, it thus remains unclear why this property has been so strongly conserved. Perhaps max homodimers represent a non-DNA binding, intermediary state that exists to accelerate the transition from myc-max to mad-max heterodimers that accompanies terminal dierentiation in some in vivo systems Hurlin et al., 1995a) . Why this should be more eciently accomplished by max homodimers than by monomers is presently unknown.
Materials and methods
Construction of max(USF)
We used the polymerase chain reaction (PCR) to construct a chimeric molecule in which the HLH-ZIP domain of max was precisely replaced with that from USF (Gregor et al., 1990) . Codons 2 ± 27 and 94 ± 160 of the 160 amino acid isoform of max (Blackwood and Eisenman, 1991) were separately ampli®ed using Pfu DNA polymerase (Stratagene, LaJolla, California). The ampli®ed fragments were designated max 5' and max 3', respectively.
Similarly, codons 213 ± 292 of USF were ampli®ed and designated USF. The sequences of the oligonucleotide primers were: max 5' (forward): 5'-GGC GGA TCC GAT AAC GAT GAC ATC GAG GTG-3'; max 5' (reverse): 5'-CCT ACG TTT TCG TTC CAG TGC A-3'; max 3' (forward): 5'-GAG AAG GCG AGG TCA AGT GCC-3'; max 3' (reverse): 5'-GCG CAA GCT TGC CCC GAG TGG CTT AG-3'; USF (forward): 5'-GAC AAG ATC AAC AAC TGG ATC GT-3'; USF (reverse): 5'-AAG CAG CAG ATT CTT GTT TTT AAG-3', where italics indicate engineered GC clamps' and restriction sites to facilitate subsequent cloning. All three fragments were ampli®ed concurrently and under identical conditions in a volume of 100 ml that contained 16PCR buer (Stratagene), 50 mM of each dNTP, 1.5 mg of each phosphorylated primer, approximately 10 ng of each full-length cDNA and 2.5 units of Pfu polymerase under the following conditions: 1 min, 948C; 1 min 568C; 30 s 728C for a total of 35 cycles. The products were then puri®ed from a 4% Nusieve agarose gel (FMC Bioproducts, Rockland, ME). The max 5' and USF fragments were ligated and reampli®ed as described above using the max 5' (forward) and USF (reverse) primers. Following the puri®cation of this fragment, it was ligated with max 3' followed by another 35 cycles of ampli®cation using the max 5' and max 3' primers using 1 min extension times. The ®nal product was digested with BamHI and ligated into BamHI+EcoRV-digested pBluescript SK + (Stratagene). The entire insert was then sequenced in both directions, using an Applied Biosystems Model 373 automated DNA sequencer, and shown to encode the entire chimeric max(USF) coding region except for its initiation methionine codon. The insert was then cloned into the pQE9 bacterial expression vector (Qiagen, Chatsworth, CA) which allowed max(USF) to be expressed as an amino-terminally tagged hexahistidine fusion protein (Prochownik and VanAntwerp, 1993) . To express the full-length protein in unmodi®ed form, the max(USF) cDNA in the abovedescribed pBluescript vector was re-ampli®ed with the original max 3' primer and a new max 5' primer which contained a synthetic ATG initiation codon and Kozak sequence (underlined): 5'-CGC GGA TCC TAG GAA ATG TCC GAT AAC GAT GAC ATC GAG G-3'. Following BamHI digestion and a ®lling reaction with the Klenow fragment of DNA polymerase, the fragment was agarose gelpuri®ed and ligated into the blunt-ended XhoI site of the pSVLneo eucaryotic expression vector (Zhang et al., 1997) . Sequencing was again performed to con®rm the orientation and ®delity of the sequence.
Yeast two hybrid studies
All studies were performed in the Y153 yeast strain as previously described . Both max and max(USF) cDNAs were ampli®ed by PCR, using the max 5' (forward) and max 3' (reverse) primers, and cloned as Bam or Bam ± HindIII fragments into the GBT9`bait' or pGAD424`prey' vectors (Bartel et al., 1993) as full-length clones lacking only the 5'-initiator methionine codon. In addition, the following cDNAs were ampli®ed and cloned into either one or both vectors as indicated in Table 1 : c-myc (codons 362 ± 439) (Stanton et al., 1984) ; Mad1 (codons 88 ± 160) ; Mxi1 (codons 24 ± 124) (Zervos et al., 1993; ; Mad3 (codons 48 ± 150) (Hurlin et al., 1995b) , and Mad 4 (codons 46 ± 152) (Hurlin et al., 1995b) . Selection of double transformants was performed initially on SC plates containing glucose, adenine, and uracil, and lacking leucine and tryptophan. The acquisition of histidine prototrophy was assessed by growth on similar plates lacking histidine in the presence of 30 mM 3-aminotriazole (Sigma, St. Louis, MO). In situ b-galactosidase assays were performed as previously described after transferring the colonies to nitrocellulose ®lters layered over EGG plates and allowing an additional 2 ± 3 days of growth.
Western blotting
Yeast extracts were prepared as described previously . Brie¯y, 50 mg of total protein was resolved by SDS-12% polyacrylamide gel electrophoresis and transferred to an Immobilon-P membrane (Millipore, Bedford, NY) using a semi-dry electroblotting apparatus (Owl Scienti®c, Cambridge, MA). All blocking steps and antibody incubations were performed in phosphate-buered saline (PBS)+0.1% Tween 20 (Sigma) containing 5% non-fat dry milk. Blots were then incubated with rabbit polyclonal antibodies directed against either DNA binding domain (1 : 500) or the activation domain (1 : 2000) of the yeast Gal4 protein (Upstate Biotechnology, Lake Placid, NY). After exhaustive washing, the blots were incubated with horseradish peroxidase-linked goat-anti-rabbit IgG (1 : 1000) (Santa Cruz Biotechnology, Santa Cruz, CA) followed by development of the blots using an enhanced chemiluminescence kit according to the directions of the supplier (GIBCO-BRL, Grand Island, NY). Electrophoretic mobility shift assays (EMSAs) NH 2 -terminally tagged hexahistidine fusion proteins were puri®ed to at least 90% homogeneity as previously described (Prochownik and VanAntwerp, 1993) . In addition to the max and max(USF) proteins described above, these included c-myc (amino acids 348 ± 439) (Prochownik and VanAntwerp, 1993) , Mad1 (amino acids 2 ± 227), Mxi1 (amino acids 38 ± 228), Mad 3 (amino acids 2 ± 206), and Mad 4 (amino acids 2 ± 209).
All recombinant proteins were dialyzed against 26 binding buer (Prochownik and VanAntwerp, 1993) , snapfrozen in small aliquots in liquid nitrogen, and stored at 7808C. Approximately 20 ng of each protein was used in a binding reaction which also included 1 mg of polydI : dC (Boehringer-Mannheim, Indianapolis, IN) and 100 pg of the double-stranded EO(GAC) consensus E-box oligonucleotide (Prochownik and VanAntwerp, 1993) end-labeled in a standard polynucleotide kinase reaction to a speci®c activity of at least 10 8 d.p.m./mg with 32 P-g-ATP (sp. act. 43000 Ci/ mmol, New England Nuclear, Boston, MA). The sequences of the palindromic oligonucleotide was: 5'-GGA AGC AGA CCA CGT GGT CTG CTT CC-3'.
CK II-mediated phosphorylation of recombinant max and max(USF) proteins was achieved by incubating 20 ng of each protein with 5 ml of rabbit reticulocyte lysate (Promega, Madison, WI) in a ®nal volume of 15 ml of 26binding buer containing 5 mM ATP at 378C for 30 min (Prochownik and VanAntwerp, 1993) . 5 ml of 26binding buer containing 10 4 d.p.m. of labeled oligonucleotide plus 1 mg of polydI : dC was then added and the incubation continued at room temperature for an additional 20 min prior to electrophoresis.
Labeling of max and max(USF) proteins was performed under conditions identical to those described above except that 10 mCi of 32 P-g-ATP was added to the reticulocyte lysate. Yeast lysates were prepared from 10 ml of logarithmically growing cells. Cells were pelleted by centrifugation, washed twice in PBS, and resuspended in a minimal volume of 2 6 binding buer containing 1 mg/ml each of aprotinin, leupeptin, and pepstatin (Boehringer-Mannheim) and 2 mM phenylmethyl sulfonyl¯uoride (PMSF) (Sigma). Following a single freeze-thaw step, the extract was sonicated on ice for 30 sec, clari®ed by centrifugation (14 000 g for 10 min) at 48C and stored at 7808C. 20 mg of clari®ed yeast lysate was used in each binding reaction. Reactions were incubated at room temperature for 20 min prior to electrophoresis on a 4% non-denaturing polyacrylamide gel which was then dried and processed for autoradiography.
Mammalian cell culture
NIH3T3 cells were maintained in Dulbecco's modi®ed Eagle's minimal essential medium (D-MEM) (GIBCO-BRL) supplemented with 2 mM glutamine, 100 U/ml penicillin G, 100 mg/ml streptomycin, and 10% supplemented calf serum (Hyclone, Logan, UT). The 32D clone three murine myeloid cell line (Valtieri et al., 1987) was maintained in RPMI-1640 (GIBCO-BRL) medium supplemented with glutamine and antibiotics as described above plus 10% fetal calf serum and 10% interleukin-3 (IL-3)-conditioned medium obtained from the WEHI-238 B-cell line.
